Skip to main content

Diagnostic Utility of Next-Generation Sequencing-Based Panel Testing in 1,273 Patients With Suspected Cystic Kidney Disease

National Society of Genetic Councelors
41st Annual Conference

NSG 2022

Nashville, TN, November 16 - 20, 2022

Poster presentation: Diagnostic utility of next-generation sequencing-based panel testing in 1,273 patients with suspected cystic kidney disease

Authors: Tapper E, Gall K, Huusko J, Scocchia A, Hathaway J, Bernal M, Saarinen I, Rantanen M, Schleit J, Kangas-Kontio T, Pietila T, Gentile M, Salmenperä P, Paananen J, Myllykangas S,  Koskenvuo J

Specialties: Cardiology, Endocrinology, Genetics

Disclaimer:  One or more of the authors of this publication were employed at the time by Blueprint Genetics, a subsidiary of Quest Diagnostics.